Medical Services (CE) (USOTC:MSITF)
Historical Stock Chart
From Aug 2019 to Aug 2024
![Click Here for more Medical Services (CE) Charts. Click Here for more Medical Services (CE) Charts.](/p.php?pid=staticchart&s=NO%5EMSITF&p=8&t=15)
EDMONTON, Alberta, May 30 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pink Sheets: MSITF) signed a sales contract that will generate in excess of 2 Million US in cashflow over the next year. The key part of this contract is that the payment terms for product are acceptable to the Company's bankers. In dealing with Companies from under-developed countries, payment terms for products often become the biggest sales issue. The funds will be used to expand the distribution network and develop an aggressive marketing plan for existing products and new products that have been developed and are available for the market. The company continues to sell product in Southeast Asia, Africa and Eastern Europe. The Company gets requests every week from companies wishing to act as distributors of the VScan products. Test marketing of the new products shows that there will be a significant demand for them.
About VScan
The VScan rapid test kit is a single use, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, Malaria, West Nile, Syphilis and Prostate Cancer. The kits cannot be sold in Canada. Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/.
NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in company reports and other filings with regulatory bodies.
DATASOURCE: Medical Services International Inc.
CONTACT: Robert Talbot of Medical Services International Inc.,
+1-780-430-6363
Web site: http://www.medicalservicesintl.com/